#United States #Irvine #blood pressure #Esperto Medical #Resonance Sonomanometry

Esperto Medical's Latest Endeavor in Patient Monitoring

In an impressive move that reflects the growing interest in health technology, Esperto Medical™, Inc., a pioneering healthtech startup focused on critical care and remote patient monitoring, has successfully completed an oversubscribed Series A financing round. This financial boost is a significant step towards advancing their groundbreaking technology, Resonance Sonomanometry™ (RSM), which aims to transform the landscape of blood pressure monitoring.

Significant Backing for Innovation

The Series A round was co-led by notable investors Catalyst Health Ventures and Bold Capital Partners, boasting additional support from Wavemaker Three-sixty Health, Free Flow Ventures, Fund@Caltech, and Maverick Ventures. This diverse pool of investment partners underscores the compelling potential of Esperto's RSM technology and the crucial need for innovation in healthcare.

With the financing secured, Esperto Medical plans to accelerate the productization and clinical testing phases of its Resonance Sonomanometry™ technology. RSM represents a significant leap forward in noninvasive, continuous blood pressure monitoring, distinguished by its unique utilization of sound waves at various frequencies to gauge blood pressure directly within arteries.

Advantages of Resonance Sonomanometry

One of the standout features of RSM is its calibration-free operation. Unlike traditional methods that often require extensive calibration and can yield variable results, RSM simplifies the setup, making it user-friendly for medical personnel and patients alike. The wearable device's versatility allows it to effectively monitor blood pressure across multiple areas of the body, including arms, legs, and necks — catering for a broad spectrum of patients.

According to Alaina Rajagopal, MD, PhD, cofounder and Chief Medical Officer of Esperto, the flexibility of RSM enhances its application in cardiovascular monitoring. Rajagopal emphasized that the technology is designed to comfortably accommodate all patients, which could fundamentally shift how healthcare providers approach blood pressure management.

Future Prospects and Leadership Insights

Joshua Phillips, Managing Partner of Catalyst Health Ventures, expressed his enthusiasm for RSM, highlighting its unique competitive advantages. He noted, "RSM is not only an innovative monitoring technology but holds potential for both hospital and personal use." This versatility arouses hopes for a transformative impact on patient monitoring systems across medical facilities.

In conjunction with the financing, Phillips and Helen McBride, PhD, a Partner at Bold Capital Partners, are set to join Esperto's board of directors. Their extensive experience in investing and healthcare technology will be invaluable as the company aims to bring RSM closer to commercialization.

McBride remarked, "Having tracked this technology from its inception at Caltech, I’m excited about the trajectory Esperto is on to integrate RSM into clinics and beyond." Her insights reflect the anticipation surrounding the functionality of RSM as it approaches the commercialization phase.

CEO Aditya Rajagopal, PhD, expressed his gratitude toward the new investors, emphasizing the potential benefits RSM will bring to patients, healthcare providers, and the overall system. He noted the significance of advancing a solution that addresses the long-held challenges of accurate and noninvasive blood pressure monitoring.

Looking Ahead

Esperto Medical has already been recognized as Octane's Best Emerging Disruptor of 2024, showcasing its commitment to pushing the boundaries of healthcare technology. As the company progresses, the focus remains on expanding access through revolutionary noninvasive diagnostic technologies. The medical field is on the cusp of significant breakthroughs, and Esperto is ardently dedicated to making healthcare more efficient and effective.

For more information on Esperto Medical and its innovative solutions, visit www.esperto.health.